• Explore /
  • Poster
  • / Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival.

Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival.

Abstract Video & Slides Poster

Authors

null

Putao Cen

The University of Texas Health Science Center at Houston (UTHealth Houston) McGovern Medical School, Houston, TX

Putao Cen , Kok Hoe Chan , Steven Canfield , Tung Shu , Neha Maithel , Varaha Tammisetti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 529)

DOI

10.1200/JCO.2023.41.6_suppl.529

Abstract #

529

Poster Bd #

L12

Abstract Disclosures

Similar Posters

First Author: Philippe Barthelemy

First Author: Ali Raza Khaki

First Author: Yongjune Lee

First Author: Lauren Christine Harshman